Impact of tDCS on Cannabis Craving in Schizophrenia

NANot yet recruitingINTERVENTIONAL
Enrollment

138

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

March 1, 2027

Study Completion Date

June 20, 2027

Conditions
SchizophreniaCannabis Use Disorder
Interventions
DEVICE

tDCS

"tDCS will be delivered using this electrode montage: anode on the left dosolateral prefrontal cortex (L DLPFC) using F3 EEG landmark and cathode on the left temporoparietal junction (L TPJ) on the middle point between T3 and P3 EEG landmark.~The stimulation will be delivered at an intensity of 2 milliamps, for 20 minutes, five times a day, with 20 min inter sessions (it will be carried out on 5 consecutive days from Monday to Friday). Each processing day corresponds to a visit of V2, V3, V4, V5 and V6."

Trial Locations (2)

93330

Ch Ville Evrard, Neuilly-sur-Marne

Youcef Bencherif, Neuilly-sur-Marne

All Listed Sponsors
lead

Centre hospitalier de Ville-Evrard, France

OTHER

NCT05784961 - Impact of tDCS on Cannabis Craving in Schizophrenia | Biotech Hunter | Biotech Hunter